Skip to main content
Equibles

NISA INVESTMENT ADVISORS, LLC

Position in LYEL — Lyell Immunopharma, Inc.

CIK 937615 ST. LOUIS, MO
Back to LYEL Full portfolio

Position in LYEL

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$351
-$150 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 87 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LYEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,553,099 across 265 Biotechnology names. LYEL ranks #253 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 56,455 $28,042,892
2 REGN
Regeneron Pharmaceuticals, Inc.
 19,412 $12,104,158
3 TECH
BIO-TECHNE Corp
 68,452 $4,836,133
4 INCY
Incyte Corp
 26,479 $3,001,659
5 ALNY
Alnylam Pharmaceuticals, Inc.
 9,139 $2,751,113
6 DFTX
Definium Therapeutics, Inc.
 48,369 $2,275,277
7 PRAX
Praxis Precision Medicines, Inc.
 6,111 $2,045,901
8 EXEL
Exelixis, Inc.
 36,758 $2,000,002

All Filings in LYEL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $351 25
2026-03-31 $501 25
2025-12-31 $769 25
2025-09-30 $406 25
2025-06-30 $221 25
2025-03-31 $269 500
2024-12-31 $438 685
2024-09-30 $164 119
2024-06-30 $638 440
2024-03-31 $622 279
2023-12-31 $296 153
2023-06-30 $16,885 5,310
2022-12-31 $499 144
2022-09-30 $44,221 6,033
2022-06-30 $38,468 5,900